Buschwiller, France

Laure Elizabeth Simone Finet

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laure Elizabeth Simone Finet. Retrieved from https://idiyas.com/inventor/laure-elizabeth-simone-finet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovations of Laure Elizabeth Simone Finet**

Introduction

Laure Elizabeth Simone Finet, based in Buschwiller, France, is a remarkable inventor known for her significant contributions to the field of chemical synthesis. With a single patent to her name, she has demonstrated exceptional ingenuity in developing innovative manufacturing processes, particularly in the synthesis of complex chemical compounds.

Latest Patents

Finet's noteworthy patent, titled "Synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates thereto," showcases her expertise in creating a pan-RAF inhibitor. The manufacturing process includes several efficient key reactions, such as a robust and scalable palladium-catalyzed carbonylation reaction, enabling the generation of thienopyrimidine. Additionally, she incorporated a highly chemoselective platinum-based catalytic reduction of nitro groups to obtain the penultimate intermediate. The final amide coupling, executed through a mild protocol using N,N,N',N′-tetramethylchloroformamidinium hexafluorophosphate (TCFH), resulted in an adduct that boasts excellent yield, purity, and stability on a multikilogram production scale.

Career Highlights

Throughout her career, Laure has collaborated with prestigious organizations in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. Her work in these companies has significantly influenced the development of therapeutic compounds, particularly in the realms of oncology and targeted therapies.

Collaborations

Finet's partnerships with leading companies such as Genentech and Hoffmann-La Roche have enriched her professional experience and allowed her to leverage her innovative methodologies in real-world applications. These collaborations play a pivotal role in advancing the field of medicinal chemistry and in enhancing the efficacy and safety of new pharmaceutical agents.

Conclusion

Laure Elizabeth Simone Finet stands out as a notable inventor in the realm of chemical synthesis, particularly for her advancements in the synthesis of complex compounds aimed at treating critical health conditions. Her patent not only reflects her innovative capabilities but also contributes significantly to ongoing research and development efforts within the pharmaceutical industry. As she continues her work, Finet's impact is expected to resonate in future innovations and breakthroughs in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…